Article Information
History
- December 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Raymond A. Harvey, MPH1,
- Jeremy A. Rassen, ScD1,
- Carly A. Kabelac, BS1,
- Wendy Turenne, MS,
- Sandy Leonard, MPH2,
- Reyna Klesh, MS2,
- William A. Meyer III, PhD, D(ABMM), MLS(ASCP)CM3,
- Harvey W. Kaufman, MD, FCAP, MBA,
- Steve Anderson, PhD,
- Oren Cohen, M.D., F.I.D.S.A.4,
- Valentina I. Petkov, MD, MPH5,
- Kathy A. Cronin, PhD5,
- Alison L. Van Dyke, MD, PhD5,
- Douglas R. Lowy, MD5,
- Norman E. Sharpless, MD5 and
- Lynne T. Penberthy, MD, MPH5,*
- 1Aetion, Inc., New York, NY
- 2HealthVerity, Philadelphia, PA
- 3Quest Diagnostics, Secaucus, NJ
- 4LabCorp, Burlington, NC
- 5National Cancer Institute, Bethesda, MD
- ↵*Corresponding Author:
Lynne T. Penberthy, MD, MPH; National Cancer Institute, National Institutes of Health, 9609 Medical Center Dr, Rockville, MD 20850 (email:lynne.penberthy{at}nih.gov)
Posted December 20, 2020.
Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection
